Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Refractory Solid Tumors × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Skin Neoplasms 3 Kasabach-Merritt Syndrome 2 Kaposiform Hemangioendothelioma 2 Waldenstrom Macroglobulinemia 1 Refractory Solid Tumors 1 Peutz-Jeghers Syndrome 1 Neoplasms, Plasma Cell 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leiomyoma 1 Hereditary Sensory and Autonomic Neuropathies 1 Hemangioma 1 Angiomyolipoma 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02688881 2022-06-15

Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

Samsung Medical Center

Phase 4 Completed

Other solid neoplasm

Refractory Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡